Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) 是一种选择性蛋白激酶 C 抑制剂。它促进 Fas 介导的细胞凋亡,并抑制 T 细胞介导的自身免疫性疾病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 653 | 现货 | ||
5 mg | ¥ 1,590 | 现货 | ||
10 mg | ¥ 2,480 | 现货 | ||
25 mg | ¥ 4,180 | 现货 | ||
50 mg | ¥ 5,960 | 现货 | ||
100 mg | ¥ 8,250 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,990 | 现货 |
产品描述 | Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC). It has IC50s of 53, 195, 163, 213, and 175 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, PKC-ε, respectively. |
靶点活性 | PKCα:53 nM, PKCβ2:163 nM, PKCγ:213 nM, PKC:158 nM(Rat Brain), PKCβ1:195 nM, PKCε:175 nM |
体外活性 | Bisindolylmaleimide VIII acetate facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Bisindolylmaleimide VIII acetate (5 μM; 8, 12 hours) dramatically increases TRA-8-induced cell death in time-dependent and TRA-8 dose-dependent manners. Bisindolylmaleimide VIII acetate (5 μM; 6 hours) significantly decreases procaspase-8 at 4 h and completely disappears at 6 h after the combined treatment with TRA-8 [2]. |
体内活性 | Bisindolylmaleimide VIII acetate (100 μg; i.p.; every other day for three doses) results in nearly complete tumor regression combined toTRA-8. The alone treatment with Bisindolylmaleimide VIII acetate does not induce significant tumor regression [2]. |
别名 | Ro 31-7549 acetate, Bis VIII acetate |
分子量 | 458.51 |
分子式 | C26H26N4O4 |
CAS No. | 138516-31-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (119.95 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.181 mL | 10.9049 mL | 21.8098 mL | 54.5244 mL |
5 mM | 0.4362 mL | 2.181 mL | 4.362 mL | 10.9049 mL | |
10 mM | 0.2181 mL | 1.0905 mL | 2.181 mL | 5.4524 mL | |
20 mM | 0.109 mL | 0.5452 mL | 1.0905 mL | 2.7262 mL | |
50 mM | 0.0436 mL | 0.2181 mL | 0.4362 mL | 1.0905 mL | |
100 mM | 0.0218 mL | 0.109 mL | 0.2181 mL | 0.5452 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Bisindolylmaleimide VIII acetate 138516-31-1 Apoptosis Chromatin/Epigenetic Cytoskeletal Signaling PKC protein Ro 31-7549 acetate Ro 31-7549 Inhibitor Bis VIII acetate inhibit Ro 31-7549 Acetate Fas Bis VIII autoimmune Protein kinase C diseases kinase cell-mediated Bisindolylmaleimide VIII Bisindolylmaleimide VIII Acetate Bis VIII Acetate inhibitor